Dr. Weston’s research interests include the epidemiology, mechanisms of resistance, and therapy of multi-drug resistant gram-negative infections, particularly Carbapenem-Resistant Enterobateriaceae.  He works with mathematical modeling techniques to predict which patients are at high risk of CRE bloodstream infections.  He also organizes Montefiore’s participation in the CRACKLE II multicenter database of CRE infections.

Dr. Weston’s inpatient clinical work is on a service dedicated to infectious disease consultation in the intensive care and step down units of Weiler hospital.  This includes brief daily rounds with each unit to identify needs for consultation and provide antibiotic stewardship guidance.  He is a member of the Montefiore Antibiotic Stewardship Team and also sees patients in an Outpatient Parenteral Antibiotic Therapy clinic.

Dr. Weston is a graduate of Regis High School in New York.  He received his undergraduate education summa cum laude from the College of the Holy Cross in Worcester, Massachusetts.  He received a medical degree from the College of Physicians and Surgeons of Columbia University in New York.  He completed Internal Medicine residency at the Emory University School of Medicine in Atlanta, Georgia.  Dr. Weston joined Montefiore Medical Center and the Albert Einstein College of Medicine in 2013 for his fellowship in Infectious Diseases.  During Fellowship he completed a Master’s of Science in Clinical Research degree in the Einstein Clinical Research Training Program. 

Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States. Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN.  Antimicrobial Agents and Chemotherapy 2017; 61: e02349-16

A multicenter study measuring appropriateness of carbapenem use. Weston G, Jacob JT, Ray S, Varkey J, Gaynes RP.  Infection Control and Hospital Epidemiology 2013; 34: 1324-1326